Cellular uptake, cytotoxicity and DNA-binding studies of the novel imidazoacridinone antineoplastic agent C1311

Lignende værker

• Preclinical evaluation of novel imidazoacridinone derivatives with potent activity against experimental colorectal cancer.
  af: Burger, A. M., et al.
  Udgivet: (1996)
• Cell killing by the novel imidazoacridinone antineoplastic agent, C-1311, is inhibited at high concentrations coincident with dose-differentiated cell cycle perturbation.
  af: Lamb, J., et al.
  Udgivet: (1996)
• CYP3A4 overexpression enhances apoptosis induced by anticancer agent imidazoacridinone C-1311, but does not change the metabolism of C-1311 in CHO cells
  af: Pawłowska, Monika, et al.
  Udgivet: (2014)
• Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole.
  af: Roizin-Towle, L. A., et al.
  Udgivet: (1981)
• Anticancer Imidazoacridinone C-1311 is Effective in Androgen-Dependent and Androgen-Independent Prostate Cancer Cells
  af: Niemira, Magdalena, et al.
  Udgivet: (2020)